Effect of Bcl‐2 overexpression in human prostate cancer cellsin vitroandin vivo
Author:
Affiliation:
1. Departments of Urology and
2. Neurosurgery, Faculty of Medicine, The University of Tokyo and
3. National Cancer Hospital, Tokyo, Japan
Publisher
Wiley
Subject
Urology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1442-2042.1999.00102.x
Reference26 articles.
1. HugginsC StevensRE HodgesCL.Studies on prostatic cancer. II. The effect of castration on clinical patients with carcinoma of the prostate.Arch. Surg.1941;43: 209.
2. Studies on prostatic cancer; effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate.;Huggins C;Cancer Res.,1941
3. A critical analysis of tumor morphology and hormone treatments in the untreated and estrogen-treated responsive and refractory human prostatic carcinoma
4. Endocrine therapy in carcinoma of the prostate gland: 10‐year survival studies.;Emmett JL;J. Urol.,1960
5. Non‐hormone chemotherapy for prostate cancer: Principles of treatment and application to the testing of new drugs.;Raghavan D.;Semin. Oncol.,1988
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Recent advances in canonical versus non-canonical Ca2+-signaling-related anti-apoptotic Bcl-2 functions and prospects for cancer treatment;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-06
2. Targeting the Intrinsic Apoptosis Pathway: A Window of Opportunity for Prostate Cancer;Cancers;2021-12-23
3. Evasion of cell death: A contributory factor in prostate cancer development and treatment resistance;Cancer Letters;2021-11
4. Apoptotic and predictive factors by Bax, Caspases 3/9, Bcl-2, p53 and Ki-67 in prostate cancer after 12 Gy single-dose;Scientific Reports;2020-04-27
5. Preclinical Study Using ABT263 to Increase Enzalutamide Sensitivity to Suppress Prostate Cancer Progression Via Targeting BCL2/ROS/USP26 Axis Through Altering ARv7 Protein Degradation;Cancers;2020-03-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3